Now live: Pro — the full 13F research suite for serious investorsSee pricing →
a16z Capital Management, L.L.C.

Q3 2024 · 13F-HR

a16z Capital Management, L.L.C.holdings as filed

Filed 2024-11-13 · accession 0001104659-24-117708

$1.14B
Reported value
13
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
770700102HOODROBINHOOD MKTS INC$443.9M39.0%18,954,860CommonSOLE
79589L106IOTSAMSARA INC$192.3M16.9%3,995,652CommonSOLE
76155X100RVMDREVOLUTION MEDICINES INC$124.6M11.0%2,748,523CommonSOLE
565394103CARTMAPLEBEAR INC$114.2M10.0%2,802,058CommonSOLE
852234103XYZBLOCK INC$68.3M6.00%1,016,697CommonSOLE
09077V100BIOABIOAGE LABS INC$62.7M5.51%3,013,975CommonSOLE
63909J108NAUTNAUTILUS BIOTECHNOLOGY INC$50.3M4.42%17,653,917CommonSOLE
25809K105DASHDOORDASH INC$39.4M3.47%1,597,010CommonSOLE
00437E102ACCDUSDACCOLADE INC$20.8M1.83%5,398,708CommonSOLE
683712103OPENOPENDOOR TECHNOLOGIES INC$12.4M1.09%6,200,821CommonSOLE
29479A108ERASERASCA INC$7.8M0.69%2,862,500CommonSOLE
37611X209DNAGINKGO BIOWORKS HOLDINGS INC$884,8290.08%108,568CommonSOLE
23257B206CYNGN INC$224,0020.02%57,584CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.